EMPAA M XR 25/1000MG TAB

EMPAA M XR is a combination tablet containing Empagliflozin 25mg and Metformin 1000mg in extended-release formulation. This dual-action medication is designed to help manage type 2 diabetes by improving blood sugar control through two complementary mechanisms: Empagliflozin works by increasing glucose excretion through urine, while Metformin reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation allows for convenient once-daily dosing, supporting better medication adherence. Suitable for patients requiring combination therapy when monotherapy is insufficient. Always use as directed by your healthcare provider.